Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baselga

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testingJ Baselga
Anti-Cancer Drugs|January 12, 2000
New horizons: gene therapy for cancerJ Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
New therapeutic agents targeting the epidermal growth factor receptorJ Baselga
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
The EGFR as a target for anticancer therapy--focus on cetuximabJ Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Targeting the epidermal growth factor receptor: a clinical realityJ Baselga
Medicina Clinica|January 12, 1991
[Sarcoma of soft tissue]J Baselga
Breast Cancer Research and Treatment|January 1, 1994
The epidermal growth factor receptor as a target for therapy in breast carcinomaJ Baselga, J Mendelsohn
Seminars in Oncology|June 23, 2000
Systemic therapy emergenciesJ Albanell, J Baselga
Pharmacology & Therapeutics|October 1, 1994
Receptor blockade with monoclonal antibodies as anti-cancer therapyJ Baselga, J Mendelsohn
Journal of the National Cancer Institute|December 26, 2001
Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspectJ Albanell, J Baselga
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testingJ Baselga
Anti-Cancer Drugs|January 12, 2000
New horizons: gene therapy for cancerJ Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
New therapeutic agents targeting the epidermal growth factor receptorJ Baselga
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
The EGFR as a target for anticancer therapy--focus on cetuximabJ Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Targeting the epidermal growth factor receptor: a clinical realityJ Baselga
Medicina Clinica|January 12, 1991
[Sarcoma of soft tissue]J Baselga
Breast Cancer Research and Treatment|January 1, 1994
The epidermal growth factor receptor as a target for therapy in breast carcinomaJ Baselga, J Mendelsohn
Seminars in Oncology|June 23, 2000
Systemic therapy emergenciesJ Albanell, J Baselga
Pharmacology & Therapeutics|October 1, 1994
Receptor blockade with monoclonal antibodies as anti-cancer therapyJ Baselga, J Mendelsohn
Journal of the National Cancer Institute|December 26, 2001
Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspectJ Albanell, J Baselga
Pageof 17